Pharmaceutical / Drug Definition :
Decreases conduction of sinoatrial and atrioventricular (AV) nodes by inhibiting calcium influx into cardiac and vascular smooth muscle cells, inhibiting excitatory contraction. These effects prolong AV node refractoriness and decrease myocardial oxygen consumption.
FDA Label Requirements and Exceptions
Verapamil Hydrochloride
FDA Import Information
Verapamil Hydrochloride
FDA Detentions
Verapamil Hydrochloride (Verapamil Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Verapamil Hydrochloride (Verapamil Hydrochloride Suppliers)
- Processors Verapamil Hydrochloride
- Repackers Verapamil Hydrochloride
- Relabelers Verapamil Hydrochloride
- Exporters Verapamil Hydrochloride
- Importers Verapamil Hydrochloride
For more information about Verapamil Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
